Rockland Trust Co. lessened its position in Danaher Corporation (NYSE:DHR) by 3.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 45,713 shares of the conglomerate’s stock after selling 1,640 shares during the period. Rockland Trust Co.’s holdings in Danaher Corporation were worth $3,858,000 as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. Waldron LP bought a new position in shares of Danaher Corporation in the first quarter valued at about $320,000. Dowling & Yahnke LLC grew its position in shares of Danaher Corporation by 1.8% during the 1st quarter. Dowling & Yahnke LLC now owns 40,229 shares of the conglomerate’s stock worth $3,441,000 after buying an additional 695 shares during the period. Lourd Capital LLC grew its position in shares of Danaher Corporation by 44.8% during the 1st quarter. Lourd Capital LLC now owns 6,768 shares of the conglomerate’s stock worth $579,000 after buying an additional 2,093 shares during the period. Reilly Herbert Faulkner III grew its position in shares of Danaher Corporation by 3.1% during the 1st quarter. Reilly Herbert Faulkner III now owns 48,141 shares of the conglomerate’s stock worth $4,117,000 after buying an additional 1,426 shares during the period. Finally, DUPONT CAPITAL MANAGEMENT Corp grew its position in shares of Danaher Corporation by 57.7% during the 1st quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 29,923 shares of the conglomerate’s stock worth $2,559,000 after buying an additional 10,943 shares during the period. Institutional investors own 75.75% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Danaher Corporation (DHR) Stake Lowered by Rockland Trust Co.” was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was stolen and reposted in violation of U.S. and international copyright law. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/09/16/danaher-corporation-dhr-stake-lowered-by-rockland-trust-co.html.

Several equities analysts have recently issued reports on the company. Wells Fargo & Company assumed coverage on Danaher Corporation in a research report on Thursday, July 13th. They set a “market perform” rating and a $90.00 target price for the company. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub downgraded Danaher Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research downgraded Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, September 8th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $92.72.

In other news, Director Linda P. Hefner sold 10,578 shares of Danaher Corporation stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the sale, the director now directly owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the sale, the insider now directly owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 71,496 shares of company stock worth $5,916,223. 12.20% of the stock is owned by insiders.

Danaher Corporation (DHR) opened at 88.21 on Friday. The firm has a 50-day moving average price of $82.64 and a 200 day moving average price of $84.22. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.48. The stock has a market cap of $61.28 billion, a PE ratio of 28.16 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the business posted $0.90 EPS. On average, analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.63%. Danaher Corporation’s dividend payout ratio is currently 17.83%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.